Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 double-blind placebo-controlled study of etanercept in Alzheimer's disease
2009-013400-31Phase 2Completed
- Sponsor
- University of Southampton
- Start
- Jun 2010
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Etanercept with Placebo (2 arms). Primary endpoint: Safety and tolerability. Started Jun 2010; status: completed.
02
Drugs
etanercept
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2009-013400-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013400-31.